Melphalan ( l - pam ) is approved by fda for marketing Fda批准美法仑(左旋苯丙氨酸氮芥)上市
2.
The inestigators note that factors that hae probably contributed to improed surial are high - dose melphalan with subsequent autologous stem cell transplantation , thalidomide , and a continuous improement in supportie care 研究人员注意到高剂量苯丙氨酸氮芥和后续的自体干细胞移植，反应停，以及支持治疗的不断改善很可能是提高生存率的影响因素。
